NR 567 ADVANCED PHARM MIDTERM EXAM ACTUAL EXAM
COMPLETE 200 QUESTIONS WITH DETAILED VERIFIED
ANSWERS (100% CORRECT ANSWERS) /ALREADY GRADED
A+
Question 1
Which pharmacokinetic process describes the movement of a drug from its
site of administration into the systemic circulation?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
E) Bioavailability
Correct Answer: C) Absorption
Rationale: Absorption is the first pharmacokinetic phase following
administration (except for IV) where the drug enters the
bloodstream. Bioavailability is the fraction of the absorbed drug
that reaches systemic circulation.
Question 2
A drug's "half-life" (t½) is best defined as the time it takes for:
A) The drug to reach its peak plasma concentration.
B) Half of the administered drug dose to be absorbed.
C) The amount of drug in the body to decrease by 50%.
D) The drug to exert half of its maximum therapeutic effect.
E) The drug to be completely eliminated from the body.
Correct Answer: C) The amount of drug in the body to decrease by
50%.
Rationale: Half-life is a key pharmacokinetic parameter used to
determine dosing frequency and predict the time to reach steady
state or complete elimination from the body.
Question 3
Which term describes the process by which drugs are chemically altered into
more water-soluble forms, primarily in the liver, for easier excretion?
,A) Absorption
B) Distribution
C) Metabolism
D) Excretion
E) Elimination
Correct Answer: C) Metabolism
Rationale: Metabolism (or biotransformation) is the enzymatic
conversion of drugs into metabolites, usually to facilitate their
excretion. The liver is the primary site.
Question 4
What is "pharmacodynamics"?
A) The study of how the body handles a drug (ADME).
B) The study of how a drug affects the body (mechanism of action,
therapeutic effects).
C) The study of drug interactions with food.
D) The study of adverse drug reactions.
E) The study of drug development processes.
Correct Answer: B) The study of how a drug affects the body
(mechanism of action, therapeutic effects).
Rationale: Pharmacodynamics focuses on the biochemical and
physiological effects of drugs and their mechanisms of action,
including receptor binding and signal transduction pathways.
Question 5
A drug that binds to a receptor and produces a maximal biologic response is
known as a(n):
A) Antagonist
B) Partial agonist
C) Inverse agonist
D) Full agonist
E) Non-competitive inhibitor
,Correct Answer: D) Full agonist
Rationale: A full agonist activates a receptor to its maximum
potential, eliciting the strongest possible physiological response,
mimicking the natural ligand.
Question 6
Which route of administration has 100% bioavailability?
A) Oral
B) Intramuscular
C) Subcutaneous
D) Intravenous
E) Rectal
Correct Answer: D) Intravenous
Rationale: Intravenous (IV) administration delivers the drug directly
into the systemic circulation, bypassing all absorption barriers and
the first-pass effect, thus achieving 100% bioavailability.
Question 7
What is "first-pass metabolism"?
A) The initial metabolism of a drug by the kidneys before excretion.
B) The metabolism of an orally administered drug by the liver before it
reaches systemic circulation.
C) The breakdown of a drug in the stomach by gastric acid.
D) The binding of a drug to plasma proteins immediately after absorption.
E) The rapid distribution of a drug to highly perfused organs.
Correct Answer: B) The metabolism of an orally administered drug by
the liver before it reaches systemic circulation.
Rationale: First-pass metabolism can significantly reduce the
bioavailability of orally administered drugs, requiring higher oral
doses compared to IV doses to achieve the same therapeutic effect.
Question 8
Which of the following describes the relationship between a drug's toxic dose
, (TD50) and its effective dose (ED50), often used to assess drug safety?
A) Potency
B) Efficacy
C) Therapeutic Index
D) Half-life
E) Volume of Distribution
Correct Answer: C) Therapeutic Index
Rationale: The therapeutic index (TD50/ED50 or LD50/ED50) is a
measure of drug safety, indicating the margin between the dose
that produces a therapeutic effect and the dose that produces
toxicity. A narrow therapeutic index means a small margin of safety.
Question 9
A drug that binds to a receptor but produces no response, while blocking the
binding of an agonist, is known as an:
A) Agonist
B) Partial agonist
C) Antagonist
D) Inverse agonist
E) Competitive activator
Correct Answer: C) Antagonist
Rationale: An antagonist occupies a receptor site, preventing the
binding of an agonist and thereby blocking its effects, without
producing any intrinsic activity itself.
Question 10
What is the primary site of drug excretion from the body?
A) Liver
B) Lungs
C) Kidneys
D) Intestines
E) Skin
COMPLETE 200 QUESTIONS WITH DETAILED VERIFIED
ANSWERS (100% CORRECT ANSWERS) /ALREADY GRADED
A+
Question 1
Which pharmacokinetic process describes the movement of a drug from its
site of administration into the systemic circulation?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
E) Bioavailability
Correct Answer: C) Absorption
Rationale: Absorption is the first pharmacokinetic phase following
administration (except for IV) where the drug enters the
bloodstream. Bioavailability is the fraction of the absorbed drug
that reaches systemic circulation.
Question 2
A drug's "half-life" (t½) is best defined as the time it takes for:
A) The drug to reach its peak plasma concentration.
B) Half of the administered drug dose to be absorbed.
C) The amount of drug in the body to decrease by 50%.
D) The drug to exert half of its maximum therapeutic effect.
E) The drug to be completely eliminated from the body.
Correct Answer: C) The amount of drug in the body to decrease by
50%.
Rationale: Half-life is a key pharmacokinetic parameter used to
determine dosing frequency and predict the time to reach steady
state or complete elimination from the body.
Question 3
Which term describes the process by which drugs are chemically altered into
more water-soluble forms, primarily in the liver, for easier excretion?
,A) Absorption
B) Distribution
C) Metabolism
D) Excretion
E) Elimination
Correct Answer: C) Metabolism
Rationale: Metabolism (or biotransformation) is the enzymatic
conversion of drugs into metabolites, usually to facilitate their
excretion. The liver is the primary site.
Question 4
What is "pharmacodynamics"?
A) The study of how the body handles a drug (ADME).
B) The study of how a drug affects the body (mechanism of action,
therapeutic effects).
C) The study of drug interactions with food.
D) The study of adverse drug reactions.
E) The study of drug development processes.
Correct Answer: B) The study of how a drug affects the body
(mechanism of action, therapeutic effects).
Rationale: Pharmacodynamics focuses on the biochemical and
physiological effects of drugs and their mechanisms of action,
including receptor binding and signal transduction pathways.
Question 5
A drug that binds to a receptor and produces a maximal biologic response is
known as a(n):
A) Antagonist
B) Partial agonist
C) Inverse agonist
D) Full agonist
E) Non-competitive inhibitor
,Correct Answer: D) Full agonist
Rationale: A full agonist activates a receptor to its maximum
potential, eliciting the strongest possible physiological response,
mimicking the natural ligand.
Question 6
Which route of administration has 100% bioavailability?
A) Oral
B) Intramuscular
C) Subcutaneous
D) Intravenous
E) Rectal
Correct Answer: D) Intravenous
Rationale: Intravenous (IV) administration delivers the drug directly
into the systemic circulation, bypassing all absorption barriers and
the first-pass effect, thus achieving 100% bioavailability.
Question 7
What is "first-pass metabolism"?
A) The initial metabolism of a drug by the kidneys before excretion.
B) The metabolism of an orally administered drug by the liver before it
reaches systemic circulation.
C) The breakdown of a drug in the stomach by gastric acid.
D) The binding of a drug to plasma proteins immediately after absorption.
E) The rapid distribution of a drug to highly perfused organs.
Correct Answer: B) The metabolism of an orally administered drug by
the liver before it reaches systemic circulation.
Rationale: First-pass metabolism can significantly reduce the
bioavailability of orally administered drugs, requiring higher oral
doses compared to IV doses to achieve the same therapeutic effect.
Question 8
Which of the following describes the relationship between a drug's toxic dose
, (TD50) and its effective dose (ED50), often used to assess drug safety?
A) Potency
B) Efficacy
C) Therapeutic Index
D) Half-life
E) Volume of Distribution
Correct Answer: C) Therapeutic Index
Rationale: The therapeutic index (TD50/ED50 or LD50/ED50) is a
measure of drug safety, indicating the margin between the dose
that produces a therapeutic effect and the dose that produces
toxicity. A narrow therapeutic index means a small margin of safety.
Question 9
A drug that binds to a receptor but produces no response, while blocking the
binding of an agonist, is known as an:
A) Agonist
B) Partial agonist
C) Antagonist
D) Inverse agonist
E) Competitive activator
Correct Answer: C) Antagonist
Rationale: An antagonist occupies a receptor site, preventing the
binding of an agonist and thereby blocking its effects, without
producing any intrinsic activity itself.
Question 10
What is the primary site of drug excretion from the body?
A) Liver
B) Lungs
C) Kidneys
D) Intestines
E) Skin
